Nanopulse Laser Therapy
ConditionTBI (Traumatic Brain Injury)
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Texas Medical Branch, Galveston
About this trial
The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
Eligibility criteria
Qualifiers
Adults aged 18 years or older at the time of enrollment
Confirmed diagnosis of moderate to severe TBI (clinical assessment and radiographic evidence)
Admission to the neurosurgical or neurocritical care service with anticipated need for intracranial monitoring (e.g., microdialysis, ICP probe)
Able to initiate treatment within 48 hours of admission
Disqualifiers
Patients younger than 18 years of age
Known or suspected pregnancy (verified via urine pregnancy test for females of childbearing age)
Incarcerated individuals or prisoners
Patients with pre-existing implanted cranial devices (e.g., deep brain stimulators) that may interfere with NPLT
Trial design
Treatments tested in this trial
- Nano-Pulsed Laser Therapy (NPLT)
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov